HOME >> MEDICINE >> NEWS
Prostate cancer therapy - study suggests new molecular screening theory

(Uppsala, April 15th) -- Levels of the Smad7 protein may predict therapeutic response in patients with prostate cancer according to research published today by investigators at the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR).

"Although the 2-ME compound is in early clinical trials, no-one has fully understood the molecular mechanisms of how it causes the death of cancer cells, but not normal cells," says Dr. Marne Landstrm, the senior author of the paper published in the prestigious Journal of Biological Chemistry. "We found that 2-ME works through a protein called Smad7, and that artificially lowering the amount of Smad7 in prostate cancer cells reduced 2-ME's ability to cause cell death. This finding suggests that the levels of Smad7, and other proteins in this molecular pathway, might predict the cell-killing ability of other cancer therapeutics and thus their effectiveness for treating individual patients."

Smad7 was originally discovered at the LICR Uppsala Branch in 1997, and the team reported, in the journal Nature, that the protein stopped cell growth by inhibiting a crucial oncogene known as TGF beta. As a result of the current study, Smad7 is now thought to play a crucial role connecting the mechanisms of cell growth, governed by TGF beta, and those of cell death, governed by another oncogene, p38 MAPK.

Dr. Carl-Henrik Heldin, Director of both the Uppsala Branch and LICR's international 'TGF beta Program' cautions that the research is at a preliminary stage and that more work is now needed to investigate whether the levels of Smad7 correlate with patients' responses to different therapies. "If we can determine which patients are most likely to benefit from a particular therapeutic approach, we can reduce the possibility that a patient will undergo treatment that has side-effects but no benefit. More importantly, we may one day be able to effectively target each individual patient with the therapy-type best fo
'"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
1-212-450-1543
Ludwig Institute for Cancer Research
14-Apr-2005


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate cancer research may be faster with PSA endpoints
4. Prostate treatment decisions based on perception more than fact
5. Prostate cancer test affected by demographic and lifestyle factors
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2019)... ... May 15, 2019 , ... Benchmark , ... Northeast, today announced that its founder, chairman and CEO, Tom Grape, has received ... for his pioneering efforts over the last 30 years, which have led to ...
(Date:5/15/2019)... ... May 15, 2019 , ... ... & Nancy Yonally Coleman, Corporate trainer and Health Management Consultant, Grants Pass, Oregon ... globally was the subject of intense discussion recently on Sharon Kleyne’s internationally syndicated ...
(Date:5/14/2019)... ... May 15, 2019 , ... Women’s Excellence is pleased to announce ... Midwives at Women’s Excellence specialize in prenatal care and a variety of women’s health ... Clarkston, MI 48346. The main Clarkston office for Women’s Excellence is in Suite ...
(Date:5/14/2019)... ... , ... Impact Advisors, a leading provider of clinical, revenue ... Stanley, Vice President, has been named one of the “Top 25 Consultants” of ... been recognized in the Excellence in Healthcare category. He will attend the Top ...
(Date:5/14/2019)... ... , ... A high number of HIV cases among the LGBTQ community’s African-American ... area and the southern United States. Specifically, the sub-groups at greater risk of ... (MSM) and transgender people of color ages 13 to 34. In response, the ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... TORONTO (PRWEB) , ... May 16, 2019 , ... ... Definiens and Dr. Peter D. Caie, Senior Research Fellow at St. Andrew ... at 9am EDT (2pm BST/UK) to learn about a deep learning based image ...
(Date:5/16/2019)... (PRWEB) , ... May 16, 2019 , ... Though Nefertiti’s ... Stanley Jacobs—has been available via Amazon since April 2019, the author is officially celebrating ... The catered event is invite-only from 5 to 6:30 p.m., then opens to the ...
(Date:5/15/2019)... ... May 15, 2019 , ... Stratodesk, a ... thanks to the Stratodesk/ViewSonic SC-T25 Citrix Ready workspace hub. Gaston County has taken ... in order to deliver advanced endpoint computing to their entire VDI. With the ...
Breaking Medicine Technology:
Cached News: